Complications of transplantation by Putnam, CW & Starzl, TE
1 
During the last decade whole-organ trans-
plantation, particularlv of the kidney, has 
become increasingly established as a sophis-
ticated kind of patient service. As a con-
sequence, transplantation centers have been 
started in almost everv part of the world, In 
the United States there are few major medi-
cal schools that do not have the capability of 
carrying out transplantation of at least the 
kidney. Medical students, house officers, 
and faculty members are being called upon 
increasingly to participate directly or indi-
rectly in the management of the resulting 
complications and problems. 
It is the purpose of this chapter to discuss 
the many things that can go wrong after 
whole-organ transplantation and to indicate 
what may be done of a corrective nature. As 
will become evident, the complications stem 
from one or more of the following etiologic 
factors: (1) preexisting organ failure; (2) 
technical imperfections in the performance 
of transplantation; (3) inability to control 
rejection of the new organ; (4) side effects of 
immunosuppressive agents given to prevent 
rejection; and (5) other coincidental disease 
not. related either to organ failure or to im-
munos u ppresslon. 
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SPECIAL ANESTHETIC CONSIDERATIONS 
With transplarrtation of either the kidney 
or liver, the patient enters the operation 
with a well defined loss of certain metabolic 
pathways by which anesthetic agents are de-
toxified or excreted or both. 
Renal Transplantation 
The anesthetic complications facing renal 
homograft recipients during their trans-
plantations are the consequence of uremia. 
If homograft function is prompt and ade-
quate, many of the potential problems such 
as Huid overload or hyperkalemia will be 
speedily relieved. However, not all homo-
grafts achieve a remedial level of function 
intraoperatively, and the safest approach to 
the anesthetic management of these patients 
is to assume that prompt urine excretion 
will not occur. 
There are no specific cOlltraindications to 
any of the common inhalant anesthetic 
agents. Considerable care must be exercised 
in the choice and administration of muscle 
relaxants, however. In 1964, Virtue87 cau-
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TABLE 1 INCIDENCE OF PROLONGED MUSCLE PARAL YSIS* 
Number Number with 
Muscle Relaxant Drug of Patients Prolonged Weakness Percent Significance 
Gallamine 15 9 20 1 .' 
:Ui f p = <0.01 d-Tuho<curarine 19J 7 
Total :20() 10 4.11 (of all cases) 
*Fmlll ,\ldrete. J. A .. Daniel, W .. O'Higgins, J W., Homatas, J, and Slarzl, T E.: Analysis of Anesthetic-Related 
Morbidity in Human Recipients of Rellal Homografts .. 11I1'.I/it. & Allalg., 50:c12l, J~J7L 
tioned against the lise of the depolarizing 
agent succinylcholine in recently dialyzed 
patients, in whom hepatic pseudocholines-
terase, upon which succinylcholine inactiva-
tion depends, may sometimes be nearly ab-
sent. Although Sarmina et al.so have utilized 
succinylcholine in their recipients without 
incident, our anesthesiologists generally 
prefer to limit its use to induction, particu-
larlv if the patient has any evidence of 
hepatic insufficiencv or hyperkalemia. 
Prolonged muscle paralysis following 
successful transplant procedures was ob-
sen'ed by Aldrete et al. in 10 (4.R per cent) 
of 206 patients who received the non-
depolarizing agents gallamine or d-tubo-
curarine Crable 1) for muscle relaxation.' 
In addition to decreased muscle strength, 
respiratory function was inadequate in these 
patients and prolonged ventilatory SUppOrL 
was required. The complication occurred 
significantly more frequently with gallamine 
than with d-tubocurarine. With either 
agent, the paralysis was not uniformly 
prevented by the administration of appro-
priate doses of anticholinesterase-type 
drugs. l I t is hardly surprising that this 
problem does occur, since gallamine in nor-
mal animals and man is excreted almost 
entirely bv the kidney and d-tubocurarine 
is removed by a renal pathwav at about a 
90 per cent level. 
I n renal recipients, continuous electrocar-
diographic surveillance intraoperatively is 
essential to detect and treat cardiac arrhyth-
mias before potentially lethal conduction 
defects supervene. Most such arrhythmias 
are directly related to disordered potassium 
balance. Of particular concern are preop-
erative serum potassium concentrations 
above 6 mEq. per liter or below 2.5 mEq. 
per liter. Attention should be directed to 
the serum potassium concentration before 
the final pretransplantation dialysis. If this 
value exceeds 6 mEq. per liter, it may be 
lowered temporarily by a single hemo-
dialysis but a rebound hyperkalemia will 
frequently occur intraoperatively, as has 
been emphasized by Aldrete.2 
A fall of 25 per cent or more of the 
systolic blood pressure is common during 
renal transplantation. I Since most recipients 
enter the operating room hypertensive, 
such a decline is rarely of clinical impor-
tance. In actuality, it frequently signifies a 
restoration toward normal phvsiology by 
virtue of removal of the diseased kidneys 
and the provision of adequate renal func-
tion. 
Chronic anemia also is a nearly universal 
preoperative finding and need not cause 
concern. Patients with uremia tolerate this 
condition well and preparatory transfusion 
is usually not indicated. In fact, preopera-
tive transfusions may precipitate cardiac 
failure since a compensatory increase in 
plasma volume has usually already oc-
currecl,29 Instead, blood loss is replaced 
volumetrically during the transplantation 
with fresh packed red cells. 
Aldrete has described intraoperative 
hyperpyrexia in a few cases of renal homo-
transplantation. The explanation for this 
complication bas not been defined. al-
though it may have been related to the prior 
administration of heterologous antilympho-
cyte globulin (ALG). In any case, it is im-
portant to monitor the intraoperative body 
temperature. 
Hepatic Transplantation 
With transplantation of the kidney, phar-
macologic considerations must take into ac-
count the loss of a renal excretory pathway. 
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With hepatic replacement the problem is in-
finitely more complex since so many drugs 
commonly in anesthetic use are either pro-
cessed in some way or other by the liver 01' 
else have the capability of injuring the liver. 
In addition, the liver operations tend to 
be long and bloody. Finally, with liver re-
placement (orthotopic transplantation) a 
major hemodynamic insult is incurred in-
traoperatively when the inferior vena cava 
and portal vein are temporarily occluded 
dming the an hepatic phase while the new 
organ is being sutured in place. Pappas et 
al.(il have showll that the cardiac output dur-
ing this critical time may be reduced to one-
half or less of the prior state. 
The complex anesthetic management 
problems of liver transplantation were 
worked out and described in dctail b\ Al-
drete.HH The essentials for success in~lude 
extensive monitoring of such diverse meas-
urements as arterial and central venous 
pressures, electrocardiogram, urine output, 
and blood pH, electrolytes, glucose, and 
blood gases. There must be provision for 
multiple intravenous inlets. When possible, 
Aldrete has preferred inhalation anesthesia 
with ftuoroxene added to a nitrous oxide-
oxygen mixture and combined with muscle 
relaxants as needed. 
Other Organs 
For heart, pancreatic, and lung transplan-
tation, there have not been such specific 
problems of drug detoxification. 
TECHNICAL COMPLICATIONS 
Errors in technique during the perform-
ance of renal or hepatic transplantation 
have made substantial contributions to the 
post-transplantation morbidity and mortali-
ty. Because of the obviously greater tech-
nical complexity of hepatic transplantation, 
technical complications have been and COI1-
tinue to be more frequent after this proce-
dure than after renal transplantation. More-
over, with either procedure a technical 
error that ill tbe ordinary surgical setting 
might be of little or no consequence may, in 
the face ofimmunosllppression, prove to be 
a clinically devastating or fatal one. for this 
reason, ever,\, effort must be made to achieve 
an anatomic'ally and physiologically accept-
able result at the time of surgery. 
Renal Transplantation 
The techni<lues used in the construction 
of the vascular anastomoses in renal trans-
plantation have been well standardized,87 
and it is extremely unusual to encounter 
vascular problems postoperatively. For ex-
ample, in our first 64 cases of renal trans-
plantation, there was only one case of arte-
rial thrombosis and none of venous 
occlusion. Since that time, there have been 
instances of complications related to either 
vascular anastomosis but those leading to 
loss of the organ have been uncommon. 
From time to time, however, in the course 
of revascularization, the anatomic situation 
of the donated kidney has been such that it 
has been impossible to completely revascu-
larize it. Most frequently, a small polar arte-
rial branch must be sacrificed ill the course 
of donor nephrectomy or else it proves to be 
too tiny for successful reanastomosis. The 
consequence of accepting incomplete revas-
cularization is the production of a regional 
infarct which, in certain instances, may be as 
large as one-third of the kidney mass. In our 
experience the only adverse effects of even a 
large infarct have been transient hyperten-
sion and early postoperative hematuria. 
In contrast to vascular problems, urinary 
tract complications have been encountered 
frequently. Several of the leading centers in 
renal transplantation ha\'e extensively re-
viewed their experiences with this kind of 
complication.47 , 48, 60, 7;;,!11 However, for the 
purposes of this discussion, we have chosen 
as illustrative material a review of 216 con-
secutive patients from our series.H] 
In these 216 recipients, 234 kidneys were 
transplanted. In 17R instances, urinary 
drainage was reconstituted with ureteroneo-
cystostomy as depicted in Figure 1. The 
urinary tracts of the other 55 kidneys were 
reconstructed wi th u reteroureterostomies 
(Fig. 2). In most instances, this latter proce-
dure was performed even though uretero-
neocystostomy was technically feasible. 
However, in a minority, ureteroureteros-
tomy was performed eithcr because the 
homograft ureter was too short to reach the 
('[{'xl rotltilluf(i Oil tHlg{' 748.) 
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Figure 1 Ureteroneocystostomy. A, The incision in the dome of the bladder is usually no more than 1.5 cm. B. De-
velopment of the submucosal tunnel. Often the more lateral counterincision is not necessary. C and 0, Placement of the 
ureter within the tunnel. The passage through the muscular layers should be widely dilated. 
"""~-"-------"------------' 
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Figure 1 Continued" E and F, Trimming of the ureter. G through j, Formation of a flat nipple. K, Completed uretero-
vesical anastomosis. The sutures are placed with 5-0 or 6-0 plain catgut on a swaged needle. (From Starzl, T. E., et al.: 
Urological Complications in 216 Human Recipients of Renal Transplants. Ann. Surg", 172:1, 1970.) 
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Figure 2 Ureteroureterostomy. A, Incision for bilateral nephrectomy and splenectomy: The ureter is tied just below 
the ureteropelvic junction (a). The lower incision (b) is for kidney transplantation. B, Recipient site for transplantation, 
showing the recipient ureter being delivered into the iliac fossa by gentle traction. C and 0, The vascular anastomoses 
have been completed. The donor and recipient ureters are positioned to be adjacent to each other and are tailored. 
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Figure 2 Continued. Single layer anastomosis performed with 6-0 or 7-0 sil k swaged on fine cardiovascular needles. 
In 0 is shown a longitudinal section with correct placement of the silk sutures. Note the intact mucosa, with no sutures 
extending into the lumen. (From Starzl, T. E., et al.: Urological Complications in 216 Human Recipients of Renal Trans-
plants. Ann. Surg., 172:1, 1970.) 
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bladder, or because of other anatomic con-
siderations such as scarring of the bladder 
from previous surgery. 
With both kinds of ureteral reconstruc-
tion , there is approximately a 10 per cent in-
cidence of serious urologic complications. 
However, the two procedures differ in both 
the timing of the complication and its char-
acter. With ureteroneocystostomy the most. 
frequent complication (3 per cent) was late 
stricture which usually required reconstruc-
tion. Early complications such as urinary fis-
tula were less common and were usually 
caused by necrosis of either the distal ureter 
or the renal pelvis. In contrast , with ure-
teroureterostomy there was a relatively high 
incidence of early complications; urinary 
fistula occurred in 6 (10.9 per cen t) of the 55 
primary ureteroureterostomies. Late so-ic-
ture was not seen with this kind of recon-
struction. 
With the development of a urinary tract 
complication, prompt reoperation is indi-
cated, particularly if the difficulty occurs in 
the early postoperative period. This 
urgency for reestablishing a watertight urin-
ary system has no parallel in standard uro-
logic practice. In a patient who has the nor-
ma! capability to heal and resist infection, 
most urinary fistulas wou ld be expected to 
eventually close spontaneously. The same 
cannot be said for the recipient of a renal 
homograft, who must be treated with potent 
immunosuppressive agents that predispose 
to infection in the transplant wound and re-
tard the healing process that would ordinar-
ily close the fistula. Because of these special 
considerations, our policy has been to at-
tempt to close urinary fistulas surgically 
before the supervention of wound sepsis. 
Since potentially life-threatening compli-
cations have been observed with approxi-
mately equal frequency after each kind of 
reconstruction , a categoric recommendation 
for one method in preference to the other 
may not be warranted on statistical grounds. 
Nevertheless, it is OLir recommendation that 
ureteroneocystostomy be the first choice 
lIsLially, since it requires less technical fi-
nesse, is associated with a lower incidence of 
urinary fistula, and ensures the preservation 
of long segments of both the donor and re-
cipient ureters for later anastomosis should 
that become necessary. 
In several patients, Iymphoceles have 
been detected by intravenous pyelography 
by external compression of the patient'S 
bladder or homograft ureter (Fig. 3). In sev-
eral instances, hydronephrosis had devel-
oped with concomitant dim inution of renal 
Figure 3 A. Ureteral obstruction 3 months postoperatively, caused by a large Iymphocele (Lc) in the transplant 
wound. The bladder deformity is evident. B. After drainage of the Iymphocele the hydronephrosis was completel y re-
lieved. The patient is alive 3'/2 years after operation. (From Starzl, T. E., et al.: Urological Complications in 216 Human 
Recipients of Renal Transplants. Ann. Surg ., 172 :1,1970.) 
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homograft function. Drainage of the Iym-
phocele through the transplant incision re-
sulted in relief of the hydronephrosis and 
improvement in renal function. 
Hepatic Transplantation 
After renal transplantation, the life-
threatening \'ascular or urinary tract com-
plication may be adverted when necessary 
by removal of the homograft. With hepatic 
transplantation, however, this ultimate re-
medial step cannot be taken, and preserva-
tion of the patient's life depends upon suc-
cessful treatment of the complication 
without homograft hepatectomy. Thus, it is 
not surprising that technical misadventures 
have made a major contribution to both the 
mortality and the morbidity following liver 
transplantation. H8 
Tn the first 25 orthotopic and four auxil-
iary hepatic transplantations in the Denver 
series, technical problems were encountered 
in nearly half the cases.88 These included in-
stances of excessive ischemic damage to the 
homografts by the events of donor death or 
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during organ preservation, of thrombosis or 
kinking of the blood supply to the trans-
planted liver, and of biliary duct obstruc-
tion. 
VASCULAR COYIPLICATIONS. If hepatic 
arterial occlusion occurs early after trans-
plantation, the complication is uniformly 
lethal. Death may occur almost immediately 
from massive hepatic necrosis (Fig. 4). Al-
ternatively, delayed death from regional 
hepatic infarction with concomitant sepsis 
may follow this kind of complication. 
Venous thrombosis following liver trans-
plantation is rare. In the Denver series there 
has been one such complication; in this 
instance, anatomic anomalies of the recip-
ient portal vein and hepatic artery probably 
plaved an important role. 
BILIARY OBSTRUCTION. Failure to pro-
vide adequate biliary tract drainage has 
been the single most common technical 
error in hepatic transplantation. l3, 14,88 Our 
greatest experience has been with cholecys-
toduodenostomy, but with this kind of re-
construction we have encountered a dis-
tressing incidence of biliary obstruction, 
OT 18 
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Figure 4 The course of a 1-year-old child with extrahepatic biliary atresia who was treated with orthotopic liver 
transplantation. The hepatic artery of the homograft apparently underwent thrombosis within a few hours after operation, 
but this fact was not reflected in transaminase level rises until almost a day later. The eventual drop of the hematocrit to 
almost zero was due to massive hemolysis. (From Starzl, T. E., Brettschneider, L., Penn, I., Bell, P., Groth, C. G., Blan-
chard, H., Kashiwagi, N., and Putnam, C. W.: Orthotopic Liver Transplantation in Man. Transplant. Proc., 1 :216, 1969. 
By permission of Grune & Stratton, Inc.) 
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which in almost all instances has been at the 
level of the cystic du ct (Fig. 5). With this 
complication, there evolves a typical syn-
drome, including biochemical evidence of 
biliary obstruction, fever , and other mani-
festations of sepsis.4~ Initially, it was as -
sumed that the complication was enti rely 
the result of technical error. An ana lysis of 
four such cases by i'dartineau ,49 however, 
has demonstrated the presence of cyto-
megalovirus (eM V) in cells lining the gall-
bladder and cystic duct. Swelling and ex-
foliation of these cells into the lumen may 
have contribu ted to the obstruction of the 
cystic ducts. 
At first , . the gravity of this situation was 
not thoroughly apprec iated. In some in-
stances , the correc t diagnosis was not made 
until autopsy. When reoperation was car-
ried out in others, it was frequ ently too late. 
More recently , the diagnosis has been made 
earlier and reoperation underta ken. At 
surgery, the dilated common duct was anas -
tomosed to the hole in the duodenum left by 
taking down the previous cholecystoduo-
A 
I 
Duodenotomy 
I 
Cholecystoduodenostomy 
8 . 
denostomy to form a secondary choledocho-
duodenostomy, with or without stent sup-
port. Survival has been achieved in several 
of these cases . 
Following biliary reconstruction with 
e ither cholecystoduodenostomy o r choledo-
choduodenostomy, patients may exhibit 
septic com plications not related to obstruc-
tion. These have included cho langitis and a 
syndrome in which the patient is "flooded" 
with bacteria during rejection crises. In an 
effort to place the homograft at a distance 
from the bactericl-Iaden gastrointestinal 
tract, several recent patients have been 
provided biliary drainage with Roux-en-Y 
cholecystojejunostomy. With this technique, 
an isoperistaltic limb of jeju num exceeding 
18 inches in length is anastomosed to the 
gallbladder or, al ternatively, the common 
duct. The results thus far are encouraging. 
OTHER TECHNICAL PROBLEMS. Other 
complications directly or indirectly attribu-
table to technical errors at the time of he-
patic transplantation include hemorrhage 
caused by a generalized bleeding c1ia thesis ,26 
Figure 5 Cholangiography of hepatic homograft. Left, Technique of dye injection through a duodenotomy and the 
anastomosis. Right, Obstructed duct sys tem in a liver recipient who had primary biliary reconst ruction with chole-
cystoduodenostomy. Subsequent surgery failed to relieve the obs truction and the patient died of sepsis a iew weeks 
later. (From Martineau, G., et al.: Delayed Biliary Duct Obstruction after Orthotopic Liver Transplantation. Surgery, 
72 :604 , 1972.) 
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Figure 6 Probable mechanism of operative injury of 
the right phrenic nerve in four pediatric recipients of 
orthotopic liver homografts. Note the inclusion of the 
nerve in the bite of the vascular clamp, which has been 
placed across the suprahepatic vena cava and which 
has also included a piece of diaphragm. (From Starzl, 
T. E.: Experience in Hepatic Transplantation. Philadelphia, 
W. B. Saunders Company, 1969.) 
air embolism following clamping of the vena 
cava, right diaphragmatic palsy apparently 
caused by the vascular clamp placed too far 
superior on the suprahep;~tic inferior v.ena 
cava (Fig. 6), and infarctIOn ot the. nght 
adrenal gland in the course of reCIptent 
hepatectomy. This last complication is an 
important one for the surgeon to under-
stand, since it may be the cause of uncon-
trollable hemorrhage. The basis for the 
complication is the need to sacrifice the 
right adrenal vein which drains into the ex-
cised retrohepatic vena cava (Fig. 7). In 
about 2U per cent of our cases of orthotopic 
transplantation. the adrenal gland then has 
undergone venous infarction and has be-
come the site of hemorrhage that can be 
controlled only by removal of the gland. In 
one case, this kind of regional venous hy-
pertension with hemorrhage necessitated 
reoperatioll and probably contrihuted to the 
death of the patient. 
Figure 7 Ligation of the right adrenal vein 
in the course of recipient hepatectomy. 
Opening of the bare area of the right hepatic 
lobe has exposed the adrenal gland. The right 
adrenal vein, which is usually the only poste-
rior tributary to the retrohcpatic vena cava, is 
then ligated and divided. In about 20 per cent 
of cases, the adrenal gland will undergo in-
farction and become the site of hemorrhage 
which can be controlled only by right 
adrenalectomy. (From Starzl, T. E.: Experi-
ence in Hepatic Transplantation. Philadel-
phia, W. B. Saunders Company, 1969.) 
Adrenal 
gland 
REJECTION 
The central issue in transplantation of 
any organ is control of the .inununologi.c 
process bv which tissue that IS .not genetI-
cally identical is normally repudiated. Thus 
rej~ction - its diagnosis and its preven-
tion - dominates and infl uences all other 
events of the postoperative period. 
Hyperacute Rejection 
This is the most cOllvulsive and ruinous 
immunologic complication that may be 
visited upon homografts. The explanation 
for hyperacute rejection has been well 
worked out ill the last 4 or 5 
vears.42 , 86, 89, 92, 103, 110 As far as can be 
determined, the initiating event is exposure 
of the transplant to host blood cOIlta,ining 
preformed antibodies possessing al~tIgr~ft 
specificity. Most commonly, these antIbodIeS 
are of the cytotoxic variety and are the 
result of presensitization by exposure to 
histocompatibility or other antigens during 
blood transfusions, during pregnancy, or 
ill the course of an earlier transplantation. 
In some patients whose homografts under-
go hyperacute rejection, no preformed anti-
bodies can be identified but the assumption 
that they are present is usually made. 
The events of hyperacute rejection occur 
with great rapidity. After an organ is revas-
cularized it fails to assume a normal pink 
hue or it initially has this color but loses it 
R.H.V. 
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within a few seconds to hours and becomes 
cyanotic. Not only are antibodies absorbed 
by the transplant, but essentially simulta-
neously there is sequestration within the 
org-an of white cells, platelets, and red cells. 
Finally, there is clearance by the graft of 
clotting factors. In this way, the blood sup-
plv of the graft hecomes plugg-ed with com-
plex thrombi, and this leads to its almost in-
stant devascularization. 
Once hyperacute rejection has occurred, 
there are no known remedial steps that can 
be taken. The best course is to recognize 
that the homograft has been lost and in the 
case of the kidney to remove it promptly 
since it will predictably undergo ischemic 
necrosis. If a patient underg-oes one hypera-
cute rejection, the chances of this accident 
occurring again are greatly increased, and 
special efforts should be made to identify 
preformed antigraft antibodies before 
proceeding with a secondary trans plan-
tatiorl. 
Delayed Rejection 
I f homograft rejection occurs despite 
treatment with immunosuppressive agents, 
the process usually begins relatively early, 
within a few days or weeks after operation, 
when the onset might have been expected 
had no therapy heen given. In Figure 8 are 
illustrated some of the findings of renal 
homograft rejection in a patient whose ini-
tial treatment was with azathioprine. Typi-
cally, there is an initial period of satisfactory 
homograft function followed hy deterio-
ration of this function. In the case shown, 
the kidney performed perfectly at first, but 
after about 16 days the BUN began to rise, 
the creatinine clearance fell, proteinuria 
increased. there was a tendency to hyper-
tension (controlled by medication), and rela-
tive oliguria occurred. At the same time, the 
patient became febrile and had a leukocy-
tosis. In short, there were the findings of 
secondary failure of the homograft in a pa-
tient who exhibited a systemic febrile illness. 
It is now well known that the onset of 
rejection is no cause for despair'since this 
process is so readily reversible. In the case 
shown (Fig. 8), the primary treatment with 
azathioprine was reinforced with hea"y 
doses of prednisone with a resulting prompt 
reversal of all the adverse findings. Later, it 
became possible to drastically reduce the 
doses of prednisone required to prevent a 
recurrence of rejection, and after 5 months 
the steroid therapy was stopped altogether. 
For 91f2 of the 10 years since transplanta-
tion. this patient has been treated with 
smaller doses of the drug azathioprine than 
those that failed at the beginning of treat-
ment to prevent the onset of a moderately 
severe rejection crisis. 
It would be superfluous to devote more 
time to a description of the findings of 
rejection in organs other than the kidney 
since the changes can be so easily deduced 
from the natural functions of the organ in 
question. Suffice it to say that the cardinal 
features of delayed rejection are those of 
deterioration of homograft function plus 
the same systemic manifestations as just 
described in kidney recipients. As with the 
kidney, the reversal of the rejection process 
has been well documented with every organ 
so far tested. The specific manifestations in 
all the various organs, including the kid-
ney,87 liver,88 heart,l°2 lung,112 and pan-
creas35• 84 have been the subject of books, 
monographs, or articles. 
No matter which organ has been trans-
planted, the magnitude of immunosuppres-
sion required to prevent rejection becomes 
the dominant factor in determining the in-
cidence and severity of the complications 
whose discussion will constitute much of the 
remainder of this chapter. If the immuno-
logic barrier encountered is a low one, the 
amount of prednisone and other drugs 
required to prevent the onset of rejection 
will be small and the complications of im-
munosuppression will be accordingly re-
duced. In contrast, if major problems are 
encountered with rejection, high doses of 
the various agents must be used with pre-
dictably adverse eft'ects upon the recipient. 
In difficult cases, steroid therapy invariably 
plays a dual role of savior and villain. Since 
steroids are the only really dose-maneuvera-
ble component of any of the immunosup-
pressive regimens now in common use, re-
jection is usually dealt with by an increase in 
the daily quantities of prednisone. The graft 
can usually be salvaged but with the some-
times devastating side effects that will be 
described later. 
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Figure 8 Classic rejection crisis in a patient being treated with the double-drug combination of azathioprine (lmuran) 
and prednisone. Deterioration of renal function began 17 days after transplantation. All stigmata of rejection are present 
except for acute hypertension and weight gain, which were slJccessfully prevented by medical treatment. The homograft, 
transplanted on April 17, 1963, still functions normally 10 years later. Its appearance at biopsy after 2 years was normal. 
Acti-C, actinomycin C; LN, left nephrectomy at the time of transplantation; RN, right nephrectomy. (From Starzl, T. E., 
et al. The Reversal of Rejection in Human Renal Homografts with Subsequent Development of Homograft Tolerance. 
Surg. Gynec. & Obst., 117:385, 1963. By permission of Surgery, Gynecology & Obstetrics.) 
Chronic Rejection 
The kind of rejection that was just 
described is thought to be a manifestation of 
cell-mediated immunity. Many months or 
years after transplantation, a different kind 
of insult may come to affect a chronically 
functioning transplant. With this latter 
process, there is involvement of the .blood 
supply of the homograft. with intimal and 
subintimal thickening and eventual occlu-
sion of the arteries to the transplanted 
organ.25, 73. 87. 88 Thus, a transplanted kid-
ney, liver, heart, or other vascularized organ 
may, in the long run, have its blood supply 
squeezed off by an attack on the vascular 
tree (Fig. 9). There has been much specula-
tion that this complication represents an 
indolent humoral antibody attack upon a 
transplant by a host that has never com-
pletely forgotten its presence. 
Renal Transplantation, Rejection, and 
Hypertension 
Arterial hypertension occurs in almost 
100 per cent of renal homograft recipients 
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Figure 9 Vasc ular changes in canine renal homografts. Top, Renal homotransplant at 19 days from a dog treated 
with azathioprine and actinomycin C. There is fibrinoid necrosis of the whole wall of an interlobular artery, and the sur-
rounding tissues are heavily infiltrated by cells. Hand E (x 180). Middle, Renal homotransplant at 739 days from a dog 
treated with 6-methyl mercaptopurine. An interlobular artery shows diffuse intimal thickening by fibrous tissue. Ela stic 
counterstained with hematoxylin and van Gieson (X 30). BOllom, Renal homotransplant at 330 days from a dog treated 
with azathioprine and actinomycin C. An interlobular artery shows marked fibrou s intimal thickening which has almost 
obliterated the lumen of the vessel. The internal elastic lamina ha s been ruptured. Elastic counterstained with hema-
toxy lin and van Gieson (X 160). (From Starzl , T. E. : Experience in Renal Transplantation Philadelphia, W. B. Saunders 
Company, 1964.) 
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at some time after operation. The greatest 
incidence is during the first 6 months. With 
rejection, the factors contributing to a rise in 
blood pressure include fluid overload due to 
failure of normal urine excretion, the hy-
pertensive effect of high -dose steroid ad-
ministration, and the presence of a renin-
angiotensin response that is apparently 
caused by the ischemia associated with rejec-
tion. Later in the course, this early hyper-
tension very often recedes in successful 
cases but with chronic rejection it may re -
turn. The hypertension in renal homograft 
reci pients has been thorough Iy discussed in 
the literature.9 • 24. 87, 107 
Recurrent Glomerulonephritis 
It may be that the glomerulonephritis 
commonly seen in renal homografts months 
or years after transplantation is also a mani-
festation of a humoral antibody phase of 
rejectionS, 52, 98 Two kinds of glomerulo-
nephritis have been seen in transplanted 
kidneys. In one variety, anti-glomeru lar 
basement membrane (anti-GMB) antibody 
has been found by immunofluorescence 
techniques, giving the typical appearance 
of the single glomerulus depicted in Figure 
10. This glomerulonephritis is the human 
analogue of the experimental pathologic 
process known as Masugi nephritis in which 
the antibody directly attacks glomerular 
basement membrane. 18 
The other kind of glomerulonephritis ob-
served in transplanted kidneys is compara-
ble to experimental serum sickness nephritis 
in which antigen-antibody complexes are 
formed outside the kid ney but eventually 
trapped there because of the peculiarly ef-
fective filtration of the renal microcircula-
Figure 10 Immunofluorescent photom icrographs of typical glomerular lesions in renal homograft biopsies. Left, 
Typical linear fixation of IgG on glomerular walls of a biopsy specimen obtained 23 months post transplanlation. The 
patient had normal renal function at the time of biopsy. Right, Typical discontinuous granular deposits of IgG 30 months 
post transplantation. 
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Figure 11 An example of glomerulonephritis 
which evolved rapidly in a cadaveric renal homo-
graft. A, Biopsy at 24 hours. There is interstitial 
edema, tubular damage, and hyaline thickening of 
the wall of an arteriole (arrow). 8, The same kidney 
at autopsy 6 days after transplantation. Homograft 
had remained oliguric during that period. There is 
patchy fibrinoid necrosis of the glomerular tuft 
capillaries and early crescent formation in Bow-
man's capsule. The tubules are severely damaged 
and the distal parts contain red cells. C, One of the 
recipient' s own kidneys. The glomerular tuft shows 
some fibrinoid necrosis and a large partly fibrosed 
crescent. These changes were part of a rapidly pro-
gressive glomerulonephritis but similar lesions may 
develop slowly over months or years in renal homo-
grafts. Hand E (X 175). (From Starzl, T. E.: Experi-
ence in Renal Transplantation . Philadelphia, W. B. 
Saunders Company, 1964.) 
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tion. When such complexes are trapped 
within the kidney, their immunofluorescent 
appearance is like that shown in Figure 10. 
The kidney slowly undergoes damage over 
the ensuing months or years by the attrac-
tion of host inflammatory responses includ-
ing the deposition of immunoglobulin and 
complement.18 By light microscopy, the his-
topathologic manifestations of these events 
or those with anti-GBM nephritis may be 
proliferative, lobular, or other kinds of glo-
merulonephritis that have distinction by 
their morphologic characteristics (Fig. 11). 
The development of glomerulonephritis 
in transplanted kidneys has been well dOCll-
men ted by reports from a number of 
institutions.27, 28, 44, 53, 54,58,71, Y8 At one time, 
the major emphasis was placed on the "re-
currence" of the original disease. It is true 
that the chance of glomerulonephritis de-
veloping in a renal homograft is greater if 
this was the orginal diagnosis, and in a 
number of such cases the appearance of the 
recurrent disease has been precisely the 
same as that of the original disease in the na-
tive kidneys. However, it has also been well 
documented that glomerulonephritis may 
OCCllr in kidneys transplanted to recipients 
whose original kidneys had been destroved 
by other than autoimmune processes.98 
Thus, glomerulonephritis has been seen in 
renal homografts transplanted to patients 
with polycystic disease, cystinosis, and pye-
lonephritis, to mention only three examples. 
Once glomerulonephritis has developed 
in a renal homograft, there is no specific 
therapy. These kidneys almost always leak 
protein. and the proteinuria may become so 
extreme as to necessitate transplant 
nephrectomy. More commonly, the protein-
uria is only one manifestation of deterio-
rating function in a course that leads to re-
transplantation or a return to dialysis. Tn a 
few of our patients with otherwise good 
renal function, stable severe proteinuria 
with albumin losses of 5 to 10 gm. per day 
has developed. When efforts have been 
made late after transpLmtation to reverse 
proteinuria with increased doses of sterQids, 
the results have usually been disappointing 
in that the objective of reversing the late 
changes is not realized and at the same time 
the penalties of increased immunosuppres-
sion must be paid. Thus, in most cases, we 
accept the residual function these hOll1o-
grafts can provide and then remove them 
when the clinical result is no longer accept-
able. 
IMMUNOSUPPRESSION AND ITS 
CONSEQUENCES 
As already stated, the condition that 
makes organ transplantation different from 
other surgical undertakings and that 
endows it with special hazards is immuno-
su ppression. I n essence, it is necessary to 
systematically weaken the immune system of 
the recipient so that a vigorous reaction 
against the alien tissue does not occur. The 
means by which this objective is achieved are 
variable. 
The Different Therapeutic Regimens 
The "modern" era of whole-organ trans-
plantation was ushered in in I ~l62 by the use 
together of the two agents azathioprine and 
prednisone, as described earlier (see Fig. 8). 
In our center, and in virtuallv every other 
one that was active in that era, these two 
agents provided the essence of treatment.34 , 
55,85,111 As already noted, the heaviest im-
munosuppression' was required early after 
transplantation, but subsequently it often 
became possible to reduce the dosage 
required to maintain chronic function of the 
homograft. If minimal doses sufficed to pre-
vent rejection long after operation, the 
prognosis of the patient proved to be good, 
whereas if protracted heavy immunosup-
pression, particularly with steroids, was 
required, the outlook was far less favorable. 
The use of azathioprine and prednisone 
together has often been referred to as 
"double-drug" therapy. 
In 1966, heterologous antilymphocyte 
globulin (ALG) was introduced at the Uni-
versity of Colorado as an addition to azath-
ioprine and prednisone in a multiple-agent 
regimen that has been known as a "triple-
drug" programY3 With this triple-drug regi-
men, ALG is used for the first few weeks or 
months after transplantation, during that 
time when the need for aggressive immuno-
suppression is the greatest. After its discon-
tinuance, long-term therapy with azathio-
prine and prednisone is continued (Fig. 12). 
In early 1971 at our institution, a system-
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Figure 12 The course of a patient who received antilymphocyte globulin (ALG) before and for the first 4 months after 
renal homotransplantation. The donor was an older brother. There was no early rejection. Prednisone therapy was 
started 40 days postoperatively because of the high rises in the serologic titers which indicated a host response against 
the injected foreign protein and which warned against a possible anaphylactic reaction. Note the insidious onset of 
late rejection after cessation of globulin therapy. This was treated by increasing the maintenance dose of steroids. (From 
Starzl, T. E., et al.: Heterologous Antilymphocyte Globulin, Histoincompatibility, Matching, and Human Renal Homo-
transplantation. Surg., Gynec. & Obst., 126:1023, 1968. By permission of Surgery, Gynecology & Obstetrics.) 
atic trial was hegun to evaluate cyclophos-
phamide, an alkylating agent, as a substitute 
for azathioprine.100,101 In all new cases of 
renal as well as hepatic transplantation, ini-
tial therapy with cyclophosphamide, predni-
sone, and heterologous ALG was given. It is 
interesting that cyclophosphamide as the 
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Figure 13 Typical triple-drug immunosuppressive 
therapy with cyclophosphamide (Cytoxan) after renal 
transplantation, Cyclophosphamide was begun the day 
before transplantation and continued postoperatively 
until there was a tendency toward leukopenia. At that 
time, therapy with cyclophosphamide was interrupted, 
and azathioprine was begun. Chronic immunosuppres-
sive therapy has been continued with azathioprine. 
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primary cytotoxic agent has produced ap-
proximately the same results as azathio-
prine. Later on in the postoperative course, 
after some weeks or months, azathioprine is 
usually substituted for cyclophosphamide 
mainlv because there is far more informa" 
tion about the long-term use of azathioprine 
in human beings than is available for 
cyclophosphamide. Thus, the typical ther-
apy for patients treated at the University of 
Colorado at the present time is shown in 
Figure n. 
In addition to these major treatment pro-
grams, a number of adjuvant measures have 
heen described although none are suffi-
ciently potent 10 prcyent the onset of early 
homograft rejection. These measures in-
clude splenectomy,H7 thymectomv,!l7 local 
homograft irradiation,:33 intravenous actino-
mycin C, and thoracic duct drainage,21. 22. 56 
Problems of Intrinsic Toxicity 
The side reactions of immunosuppressive 
agents may be mediated bv a straightfor-
ward mechanism of drug toxicity. 
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AZATHIOPRINE. In dogs, this agent has 
easily demonstrable hepatotoxicity. Doses 
comparable to those used in humans pro-
duce increases in SGOT and SGPT in essen-
tially every animal (Fig. 14). The animals 
depicted in Figure 14 also lost weight and 
became anemic. Although jaundice was not 
noted in these 18 dog's, icterus has also been 
observed in this kind of canine experiment. 
An extreme degree of hepatotoxicity of 
azathioprine is apparently a relatively spe-
cies-specific finding in the dog. Fortunately, 
it is not a consislent problem in the human 
being. Even so, we believe that liver illjury 
from this agent has been seen in patients, as 
will be demonstrated later. 
It goes without saying that the most strik-
ing and specific toxic effect of azathioprine 
is bone marrow depression if the drug is 
given in excessively large doses. 
PREDNISONE. The other immunosup-
pressive agent that has extremely important 
direct toxic effects, particularly on the gas-
trointestinal tract, is prednisone. The adre-
nal corticosteroids, whell administered over 
long periods of time, can (l) cause fatty in-
filtration or even cirrhosis of the liver, (2) in-
duce pancreatitis and diabetes mellitus, and 
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Figure 14 The toxicity of azathioprine when used 
alone or in combination with 3"S-methionine. Six dogs 
were in each of the three test groups. There were easily 
detectable abnormal ities of liver function but jaundice did 
not develop. The azathioprine doses were 1 to 4 mg. per 
kilogram per day. Note that the animals tended to lose 
weight and become anemic. (From Starzl, T. E., et al.: 
Factors Determining Short- and Long-Term Survival 
after Orthotopic Liver Homotransplantation in the Dog. 
Surgery, 58: 131, 1965.) 
(3) cause ulceration of the duodenum and 
other parts of the bowel with gastrointes-
tinal hemorrhage or perforation, to men-
tion only a few of their effects. 
Among younger patients, the life-threa-
tening complications of prednisone may be 
of less immediacy than the cosmetic effects. 
To a sensitive teenager, the most dreaded 
changes may be the development of severe 
acne, other unacceptable facial disfigura-
tions, a buffalo hump, and striae of the ab-
dominal wall or elsewhere. More will be said 
later about the role of prednisone in causing 
skeletal changes. 
CYCLOPHOSPHAMIDE. As is the case with 
azathioprine. cyclophosphamide adminis-
tration must be monitored scrupulously be-
cause of its ability to cause profound bone 
marrow depression. In addition, cyclophos-
phamide may have important effects upon 
the gastrointestinal tract. When used alone 
in large doses, it has caused diffuse or dis-
crete gastrointestinal ulceration or massive 
hepatic necrosis.6 Hemorrhagic cystitis has 
come to be recognized as a classic complica-
tion of administration of the same doses. 7H 
U nli! recently, cyclophosphamide has 
been used for its immunosuppressive quali-
ties most extensively by those interested in 
bone marrow transplantatioll.79 The agent 
was given for a few days at doses as high as 
100 mg. per kilogram per day in an effort to 
induce tolerance. In whole-organ recipients, 
cyclophosphamide has been used quite dif-
ferently, usually in doses that are little 
greater than 1 mg. per kilogram per day, 
but on a chronic basis. Under these circum-
stances, cyclophosphamide has seemed nei-
ther more nor less dangerous than azathio-
prine.100, 101 
HETEROLOGOUS ALG. Some of the most 
important side effects with ALG afflict the 
kidney. Renal damage may result if the 
ALG contains specific anti-GBM antibody 
which attaches to and injures the glomerular 
basement membrane. More commonly, an-
tibodies may be generated extrarena'Uy in 
response to the injected antigen. Then, cir-
culating soluble antigen-antibody COlll-
plexes arc formed which may lodge in the 
kidney and cause a lesion analogous to 
serum sickness nephritis. Fortunately, these 
kinds of nephritis have been seen very 
rarel y. 43, lIiI, lOG 
The most dreaded complication of he-
terologous ALG is the development of ana-
phylactic reactions, which have been ana-
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lyzed bv Kashiwagi. 40 In Ollr center, these 
reactions have caused the death of two pa-
tients in the course of the last fi years .. \n 
anaphylactic reaction is thought to result 
from all antigen-antibody union that secon-
darily triggers the release of humoral sub-
stances (from lIlast cells and other cells) 
which in turn may pass to widely distributed 
targets, especially those containing smooth 
muscle. The humoral agents that have been 
implicated in anaphylaxis of experimental 
animals or man have included histamine, 
slow-reacting substance (SRS), bradvkinin, 
and serotonin.59 Since the initiating event in 
an anaphylactic reaction is an antigen-anti-
body reaction, it goes without saying that 
the risk of this complication increases with 
repetitive exposure to foreign protein, and 
so the patient receiving ALG chronically 
should be watched carefully for any suspi-
cious sIgns. 
When an anaphylactic reaction occurs, in 
retrospect there have usnally been plenty of 
warning signs. A feeling of chest constric-
tion has been a common, seemingly minor 
complaint. If this is ignored, a later reaction 
may lead to profound cyanosis. Arterial 
blood gases were determined in some of our 
patients and the P02 was recorded as low as 
20 mm. Hg. In I he fatal cases, massive pul-
monary edema ensued which was uncon-
trollabie by any means. 
In some instances a foreboding of im-
pending death may be complained of. In 
fact the two patients who died ill our center 
from anaphylactic reactions both bitterly 
resisted the last injections of ALG they were 
given on the grounds of a premonition of 
death. 
Once an anaphylactic reaction has oc-
curred, it must be treated with great deci-
siveness and vigor. Usually the intravenous 
injection of I gm. of hydrocortisone (Solu-
CarteE) will interdict the potentially lethal 
manifestations. It lIlay also be desirable to 
give intravenous dipl~enhydramine (Bena-
dryl) and eventually evell intravenous or in-
tracardiac epinephrine rna\' become neces-
sary. 
I f the ALG has any significant amount of 
antiplatelet activity it is entirely possible for 
it to cause profound thrombocytopenia de-
spite the presence of g'Ood bone marrow 
function. 
Immunologic Invalidism 
The kind of direct pharmacologic toxicity 
just described must be borne in mind by 
anyone treating patients chronically with 
any of the drugs used in the several immun-
osuppressive regimens that have now been 
widely accepted. However, far greater in 
importance than this kind of direct toxicity 
is the immunologic illvalidislll that is delib-
erately produced, and efficiently so, by the 
agents in question. From this weakening of 
the immune system derive the most serious 
and dreaded ~omplications seen in the pop-
ulation of transplant recipients. To the ex-
tent that the immune system must be sup-
pressed in order to retain function of the 
graft, the recipient loses the capacity to react 
forcibly to other inimical environmental an-
tigens, including those of bacteria. 
Thus, an increased susceptibilitv to infec-
tion is the price for survival. If an invading 
microorganism causing an infection is a 
common bacterium against which effective 
antibiotics are available, the resulting prob-
lem can usually be dealt with. But if the in-
vading microorganism is an opportunistic 
one of normally low pathogenicity and for 
which no effective antibiotic therapy is avail-
able, the outcome is commonly tragic. 
What has just been described is a loss of 
the surveillance of the host to bacteria. It 
has become recognized that the loss of im-
munologic surveillance may have more 
wide-reclching effects including an increased 
incidence of de novo malignancies, as will be 
documented, along with a further account 
of the infectious complications, in the sub-
sequenL sections. 
COMPLICATIONS AFFECTING THE 
ESOPHAGUS, STOMACH, AND 
DUODENUM 
ESOPHAGUS. The most frequent dis-
order of the esophagus post Lransplantation 
has heen esophagitis. Invariably, this is as-
sociated with stomatitis. If a recipient com-
plains of substernal pain while eating and if 
ulcerations of the oral mucosa or lips are 
found, a presumptive diagnosis can be 
made. The painful lesions of the mouth and 
lips have been shown to be caused by the 
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herpes simplex virus, but this infection is 
frequently associated with Cal/dido albicolls 
infestation. Treatment with nysta tin UI'Iy-
costatin) oral suspension and tablets is insti-
tuted to control the Candida infection, but if 
this does not control the moniliasis, a course 
of systemic therapy with amphotericin B 
may be required. 
The dangers of monilial esophagitis, par-
ticularly when the esophageal mucosa has 
already been damaged b)' herpetic ulcer-
ation, are perforation and dissemination. A 
month a fter transplantation one of our pa-
tients incurred diffuse ulcerations and 
sloughing of the esophagus (Fig. 15), as well 
as of most of the rest of the gastrointestinal 
tract (Fig. 15), leading to death from eso-
phageal perforation within a few days. Sev-
era l other patients have died of dissemi-
Figure 15 An exampleofmoni-
lial esophagitis with diffuse ulcera-
tions and sloughing of mucosa. 
Top, The esophagus and stomach 
at autopsy. The remainder of the 
gastrointestinal tract showed simi-
lar areas of involvement. BaHam, 
The tracheobronchial mucosa wa s 
also the site of ulcerations and 
sloughing. 
nated COl/dido olbicans infection with 
multiple a bscesses in several organs. 
STOMACH AND DUODYNUM. In caring for 
patients treated with renal homotransplan-
tation, the need often arises to treat surgi-
cally a variety of non urologic intra-abdo-
minal complications. The single most 
common cause of difficulty has been gastric 
or duodenal ulceration with perforation or 
hemorrhage. Some of these complications 
developed during pretransplantation dia-
lysis. Under these circumstances, vagotomy 
plus pyloroplasty or gastric resection should 
be performed before transplantation IS 
done. since after the institution of immuno-
suppressive therapy the steroid component 
of treatment may make medical manage-
ment even more difficult. 
In a book published in 1964 based upon 
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fewer than 70 cases of renal homotransplall-
tation, it was pointed out that gastrointes-
tinal hemorrhage occurred during the early 
postoperative period in 35 of the first 42 
cases (83 per cent).87 During that era, metic-
ulous prophylactic postoperative antacid 
therapy was not being given. Subsequently, 
the magnitude of the problems has been 
reduced by providing all patients on im-
munosuppressive regimens with this kind of 
preventive antacid treatment. Nevertheless, 
by 1968. Penn et al.67 recorded eight pa-
tjents from a total of 184 consecutive renal 
recipients who had required gastric pro-
cedures because of gastroduodenal compli-
cations-six with hemorrhage and two with 
duodenal or gastric perforation. 
The problems encountered with the stom-
ach and duodenum under these potentially 
dangerous circumstances post transplanta-
tion will not he exhaustively discussed since 
they are no different from~ those that have 
been described in discussions of steroid 
therapy in patients who have not undergone 
transplantation. However, a comment is in 
order about the appropriate gastric proce-
dure. at least if the complication is hemor-
rhage. A conservative operative procedure 
has almost always been performed, cOllsist-
ing of vagotomy and pyloroplasty. In the 
vast majority of cases, the source of hemor-
rhage has been superficial ulceration of the 
gastric mucosa or gastritis, whereas in the 
remainder, relatively superficial duodenal 
ulcers have usually been responsible. With 
vagotomy and pyloroplasty. reoperation 
and resection for continuing or recurrent 
hemorrhage has beell necessary in only one 
instance. 
I n the early days of transplantation, it was 
assumed that perforation of a hollow viscus 
was almost tantamount to death. However, 
it has been learned that simple closure of 
such a perforation, provided this is carried 
out early, has a good prospect of success. 
Even under immunosuppression, the peri-
toneal G\\'ity can withstand a single insult if 
it is not of great duration and if it is effec-
tively treated. 
COMPLICATIONS AFFECTING THE 
INTESTINES 
THE SMALL BOWEL. By far the most 
common complication affecting the small 
bowel in transplant reopIents is intestinal 
obstruction from adhesions. There are sev-
eral obvious reasons. First, abdominal 
operations have usually been performed, 
most frequently to remove the diseased na-
tive kidneys or to perform splenectomy. 
Second, many such recipients have had 
peritoneal dialysis. Finally, the transplanta-
tion itself is sometimes performed intra peri-
toneally, particularlv if the recipient is a 
childR7 whose extra peritoneal space cannot 
easily accommodate an adult organ. Two of 
our first] 0 pediatric patients who had the 
intraperitoneal homograft placement 
required reoperation at a later time for lysis 
of adhesions at the transplantation site. 
Occasionally, there may be intrinsic small 
intestinal lesions. For example, in one of our 
first recipients of an auxiliary liver homo-
graft diffuse monilial enteritis developed 
and caused him to bleed to death.8~ Within 
the last few months, we have seen a kidney 
recipient in whom discrete ulcers, ap-
parently also caused by Candida alhiwll.l, de-
veloped. The condition hrst led to small 
bowel perforation, necessitating resection, 
and within a few weeks massive hemorrhage 
from a residual ulcer occurred. requiring a 
second enterectomy. The patient survived 
both procedures. 
THE COLON. Of all the gastrointestinal 
complications after organ transplantation, 
those affecting the colon have been the most 
uniformly lethal. The only formal report on 
this su~ject in the literature was by Penn et 
al.63 Bv 1969 they had collected from the 
University of Colorado case material eight 
cases of perforated sigmoid diverticulitis, 
pseudomembranous enterocolitis, granulo-
matous colitis, ulcerative colitis, or perfora-
tion due to an unrecognized iatrogenic inju-
ry. All of these patients died. Since that 
time, a patient with perforated diverticulitis 
has heen successfully treated in two stages, 
first exteriorization of a perforated sigmoid 
diverticulum and then closnre of the colos-
tomy 6 weeks later. A few other examples of 
effecti\'e treatment of perforating colonic 
lesions ha\'e becn reportcdY 
If more survivals are to be obtained when 
serious infiammatory colonic lesions occur, 
a high degree of suspicion and early opera-
tion will be necessarv. In the last 3 vears, a 
half dozen renal patIents have been'discov-
ered at autopsy to have large ulcers of the 
cecum. These renal recipients usually had 
-------- <._----
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diarrhea, frequently accompanied by gram-
negative septicemia or intermittent bright 
red rectal bleeding. Barium enema exami-
nations were normal. For such a syndrome 
we now believe that exploration and consid-
eration of a right colectomy should be enter-
tained. 
In addition to the lethal colonic complica-
tions, fecal impaction has been common, so 
severe in one case that operative relief was 
eventually necessary. There are reasons for 
this. Disturbances of bowel activity are com-
mon in both renal and hepatic hOlllograft 
recipients. Before the transplant operation 
the patient may have a hypomotility syn-
drome, or even frank ileus, because of ure-
mia.87 After transplantation there may be a 
period of poor graft function, which lllay 
perpetuate a preexisting hypomotility state. 
As soon as the patient can take liquids by 
rnouth he is given large doses of antacids, as 
described in the preceding section. At times, 
the nonabsorbable antacid gels may cause 
constipation or fecal impaction. In order to 
avoid these problems in organ recipients, 
the colon is kept empty by preoperative and 
postoperative enemas, and liberal use is 
made of stool softeners. 
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PANCREATITIS A"ID HYPERAMYLASEMIA. 
Elevation of the serum amylase is not an un-
usual finding after either renal or hepatic 
transplantation. If the patient is asympto-
matic and potential etiologic factors can be 
excluded, the laboratory finding is probably 
of little significance. However, when clinical 
signs and symptoms of pancreatitis accom-
pany the biochemical abnormality, the find-
ings become of grave prognostic signifi-
cance. 
The first report of pancreatitis after renal 
transplantation revealed that tbis complica-
tion developed in three of the first 42 con-
secutive patients (7.1 per cent) at the Uni-
versity of Colorado.87 Subsequently, most 
major transplant centers, when polled by 
Johnson and Nabseth, reported one or 
more cases of acute pancreatitis among their 
renal recipientsYs The incidence in their 
collected series was 19 cases among 1074 re-
cipients, or slightly less than 2 per cent. 
However, the true incidence of this compli-
cation can easily be demonstrated to be 
higber, if clinicai and biochemical evidence 
for the diagnosis is systematically sought. 
Penn et al.66 reviewed 301 consecutive 
renal homograft recipients; 17 patients 
(5.6 per cent) were diagnosed as haying 
proyen (12 cases) or almost certain (five 
cases) pancreatitis (Table 2). Eleven of the 
12 patients with proven pancreatitis died, 
and this complication was the major cause 
or a contributory factor to death in all 11. 
The twelfth patient with proven pancreatitis 
survived, but only after a storm v convales-
cence (Fig. 16). The five patients ~ith highly 
probable pancreatitis survived after pro-
tracted illnesses. 
In addition to the symptomatic cases of 
pancreatitis, Penn et al.65 reported an addi-
tional 43 patients (14.3 per cent) who had 
asymptomatic hyperal1lylasemia post trans-
plantation (Table 2). Many of these patients, 
who frequently had had elevations of tbe 
serum amylase even before transplantation, 
probably experienced clinically undetected 
episodes of pancreatitis at some time in their 
convalescence, but were apparently not 
thereby harmed. 
The etiology of pancreatitis in transplan-
tation patients is probably complex. Inflam-
matory changes in the pancreas are com-
mon in uremia,1 and abnormalities of the 
gland are frequently noted at the time of bi-
lateral nephrectomy and splenectomy. Op-
erative trauma to the pancreas in the course 
of the upper abdominal dissection may oc-
casionally aggravate preexisting inflamma-
TABLE 2 INCIDENCE OF PANCREATITIS IN 301 
CONSECUTIVE RECIPIENTS OF RENAL 
HOMOGRAFTS* 
Diagnosis 
Preexisting pancreatitis 
Acute pancreatitis 
Defmite 
Suspected 
Mortality 
H \ pcramylasernia 
Patients 
5 (1.7%) 
17 (5Ji'!r) 
12 
5 
lIIl7 (64.7%) 
43 (l4.7'X) 
*Data from Penn, L, Durst, A. L., and Machado, M., 
Halgrimson, C. G., Booth, A. S., Jr.. Putnam, C W., 
Groth, C. G., and Starzl. T. L: Acute Pancreatitis and 
Hvperamylasemia ill Renal Homograft Recipients. 
Arch. Surg., 105:167, E172. 
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Figure 16 Proven pancreatitis in 
a renal homograft recipient. The 
pancreatitis was complicated by 
abscess formation necessitating sev-
eral surgical procedures. An abscess 
in the left labium rriajus was drained 
75 days after transplantation CD . 
Subsequently, a sinogram (Fig. 17) 
demonstrated an extensive proximal 
extension of the abscess wh ich was 
then drained through an incision in 
the left flank ~. Sixteen days later, 
a large retroperitoneal abscess com-
municating with the first two abs-
cesses and arising from the pancreas 
was drained <J) . The serum amylase 
level remained elevated for a pro-
longed period. Graft function deter-
iorated during the treatment of the 
abscesses but partially recovered . 
(From Penn, I., et al.: Acute Pan-
creatitis and Hyperamylasemia in 
Renal Homograft Recipients, Arch. 
Surg., 105:167, 1972.) 
tion or possibly trig-ger an acute episode of 
pancreatitis. 
. H yperparath yroidism and hypercalce-
mia, which frequently complicate uremia 
(see later) , may in themselves predispose to 
pancreatitis. Three of the patients with pan-
creatitis reported by Pen n were fou nd to 
have parathyroid hyperplasia and five of the 
patients with asymptomatic hyperamylase-
mia had concomitant elevations of the 
serum calcium. One of the latter recipients 
required emergency parathyroidectomy for 
hyperplasia 46 months post transplantation . 
Cholelithiasis, hepatitis, and local or sys-
temic infections with bacteria, fungi, or 
viruses31 may also cause or predispose to 
pancreatitis and must be carefully excluded . 
Less easily documented, but probably more 
commonly of etiologic significance, a re 
drugs administered post transplantation. 
Those implicated include azathioprine,32 
corticosteroids,1s and the diure tic chloro-
thiazide l9 
Finally, ren al insufficiency may in itself 
produce hyperarnylasemia by virtue of de-
creased enzyme clearance.41 This last con-
sideration may partially explain the large 
number of patients noted to have asymp-
tomatic hyperamylasemia while on dialysis 
or during episodes of poor renal function 
post transplantation. 
Although preexisting pancreatitis is not 
of itself a contraindication to renal trans-
plantation, every effort should be made to 
diagnose and correct predisposing factors , 
including biliary trac t disease and h yper-
parathyroidism. 'When the diagnosis is 
made for the first time after transpla ntation, 
efforts are directed toward the correction of 
inciting factors, vigorous su pportive care 
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Figure 17 Sinogram taken after drainage of the first 
abscess in the patient whose course is shown in Figure 16. 
A tract (arrows) extends from the left labium majus retro-
peritoneally into the left flank. (From Penn, I. , et al.: 
Acute Pancreatitis and Hyperamylasemia in Renal 
Homograft Recipients. Arch. Surg. , 105:167, 1972.) 
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including antibiotic therapy, and the aggres-
sive treatment of complications, such as 
abscess formation (Fig. 17). Serious consid-
eration should also be given to curtailment 
of immunosuppression, particularly of the 
corticosteroid dosage. 
HYPERGLYCEMIA AND DIABETES MELLITUS. 
About one-third of nondiabetic patients 
awaiting renal transplantation manifest hy-
perglYcemia, usually without glycosuria. 
The elevated blood sugars are usually a 
manifestation of the glucose intolerance of 
uremia and are of little clinical significance. 
After renal transplantation, more than 
half of all recipients will have hyperglycemia 
of varying severity.87 In some patients, the 
biochemical abnormality simply reflects 
periods of poor renal function from what-
ever cause and is probably of no greater sig-
nificance than in the uremic patient who has 
not undergone transplantation. More com-
monly, however, the blood sligar elevations 
parallel temporally the administration of 
large doses of corticosteroids. The phenom-
enon is dose-related, usually having its onset 
when the dose exceeds 2.5 mg. per kilogram 
per day and usually resolving when the dose 
falls below 0.7 mg. per kilogram per day.65 
In about 15 per cent of patients (Table 3), 
the hyperglycemia is severe enough to 
require treatment, and in a few instances 
prodigious doses of insulin may be required 
to achieve eyen mediocre control of the fast-
TABLE 3 POSTTRANSPlANT ATION 
HYPERGl YCEMIA* 
Patients Mortality 
Severe 1l\'Per~l\'cemi<l, 
requiring pharmacologic 
therapy 
Hyperglycemia> 30 days, 
but not reqlliring 
treatment 
I ntermitlent hyperglycemia 
Occasional hyperglycemic 
episodes 
Euglycemia 
52 (17.37<) 1 
5:, (17.6'/;) 
136 (15.2%) J 
301 
- ... rt ~).'J ;0 
:\I)",o/c 
*Frolll Penn. I., Durst, .-\. L.. and "lachado. M.: 
Diabetes and Hyperglycemia in Renal Homograft 
Recipients. In preparation. 
ing- blood glucose level. -:\iore frequently, 
the hyperglycemia is less severe, transient, 
or intermittent and requires no specific 
therapy other thall attention to ciicl. In 
these milder cases of diabetes, resolution 
OCCllrs with reduction in steroid therapy, as 
mentioned previously. 
)Jot surprisingly, the mortality among pa-
tients manifesting hyperglycemia is greater 
than that among those recipients maintain-
ing euglycemia (Table 3). Although an oc-
casional patient mav die as a direct result of 
a diabetic complication such as ketoacidosis, 
the vast majority of these deaths cannot be 
attributed directly to hyperglycemia or 
frank diabetes. Instead, the most frequent 
cause of death is found to be sepsis, again 
reflecting the necessity for large-dose 
steroid administration to combat poor renal 
function. 
Nonetheless, the development of hyper-
glycemia in a previously euglycemic recip-
ient or of ketoacidosis in the previously well 
controlled diabetic recipient calls for a vigor-
ous diagnostic evaluation. This should in-
clude frequent assessments of renal function 
and a careful search for infectious compli-
cations which might initially otherwise pass 
unnoticed. Concomitantly, vigorous treat-
ment with dietary control, oral hypoglyce-
mic agents, or insulin should be undertaken 
to reestablish euglycemia, since ketoacidosis 
mav rapidly become life-threatening. 
In view of the adverse implications of 
diabetes mellitus diagnosed for the first time 
post transplantation, is it reasonable to rec-
ommend transplantation for patients whose 
uremia was caused by diabetic nephro-
pathy? Recently Najarian and his associates 
at the University of Minnesota have at-
tempted cadaveric renal transplantation in 
about two dozen patients with diabetes mel-
litus. Although the results remain distinctly 
inferior to those in comparable recipients 
treated for other renal diseases, the prog-
nosis is nonetheless considerablv better than 
that for diabetics on chronic dialysis who al-
most never survive for as long as 2 vears. It 
would therefore seem that diabetes mellitus 
could, and should, be removed from the list 
of contraindications to renal transplantation 
and the prospective diabetic recipient re-
evaluated in light of this more recent ex-
perience. Our own experience supports that 
of Najarian. 
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HEPATIC COMPLICATIONS 
A.t some time postoperatively, the major-
ity of renal homograft recipients manifest 
abnormalities of one or more of the stan-
dard liver function tests. The immunosup-
pressive program is presumably responsible 
for the high incidence of the liver dysfunc-
tion, either because of drug hepatotoxicity 
or because the consequent weakening of the 
host immune sYstem permits the frequent 
development of viral hepatitis. The dif-
ferential diagnosis of hepatotoxicity from 
hepatitis after transplantation is usually dif-
ficult and frequently impossible. Penn's68 
studies have demonstrated the extreme 
frequency with which such a perplexing dis-
tinction should be made, and Torisu et a1.105 
have shown how often this may not be possi-
ble with any diagnostic tool currently avail-
able. 
Penn et al.68 examined the preoperative 
and postoperative liver function test s in 146 
renal recipients. At some time post trans-
plantation, abnormalities in the serum 
bilirubin, alkaline phosphatase, SCOT, 
SGPT, prothrombin time, serum protein 
concentrations. or sulfobromophthalein 
(ESP) clearance developed in 88 (60 per 
cent) of the patients. The hepatic dysfunc-
tion usually appeared within the first 6 
postoperative months (Fig. 18). In most in-
stances the changes were transient and mild. 
These were accompanied by clinical com-
plaints in only a small minority. In 20 pa-
tients, however, the derangements of liver 
function were severe and persistent; four of 
TIME OF ONSET OF LIVER DAMAGE 
(88 patients) 
Months Following Transplantation 
the recipients died of hepatic failure 5 to 18 
months after transplantation. 
It is of some interest that in the series 
reported by Penn et al.68 the 66 patients 
treated with the triple-drug regimen of 
azathioprine, prednisone, and heterologous 
antilymphocyte globulin had a somewhat 
lower incidence (54 per cent) of hepatic dys-
function than the 80 patients who received 
on Iv azathioprine and prednisone (65 per 
cent). Moreover, all four of the fatalities 
were in the group receiving double-drug 
therapy. It was concluded that the magni-
tude of the problem had been less since the 
addition of ALG to the immunosuppressive 
regimen, probahly because of concomitant 
reductions in steroid and azathioprine 
dosage. 
THE QUESTION OF DRUG HEPATOTOX-
ICITY. The two drugs, azathioprine and 
prednisone, commonly employed in mod-
ern immunosuppressive programs are 
known to be potentially toxic to the liver, as 
discussed previously. The main attention 
has been paid to the hepatotoxicity of aza-
thioprine. However, the diagnosis of aza-
thioprine hepatotoxicity in patients has been 
made with certainty in only a few dramatic 
cases in which the events of hepatic dysfunc-
tion correlated temporally with the duration 
of or increases in azathioprine dosage. One 
such case is depicted in Figure 19. N ever-
theless, when biochemical or clinical evi-
dence of hepatic injury develops in the renal 
recipient receiving azathioprine, hepatotox-
icity should be suspected and consideration 
given to modification of the immunosup-
Figure 18 Time of onset in human 
renal transplant recipients of abnor-
mal ities of one or more liver function 
tests. One hundred forty-six patients 
were studied. Of these, 88 (60 per 
cent) had some evidence of hepatic 
damage, usually during the first 6 
postoperative months. This was usu-
ally mild, but in 20 patients (14 per 
cent) it was severe. (From Penn, I., 
et al.: Hepatic Disorders in Renal 
Homograft Recipients. Current Topics 
in Surgical Research, 1 :67, 1969.) 
----------------------
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Figure 19 The course of a kidney transplant recipient who appeared to have suffered liver damage from azathioprine 
toxicity. About 5 months after his first renal homotransplantation, low-grade jaundice developed and increases in trans-
aminase levels were seen. The azathioprine dose was cut immediately and further reductions were made at subsequent 
intervals. The homograft eventually failed and was removed after about 2 years. When retransplantation was performed, 
four large doses of azathioprine were given just before and after operation. Immediately, the transaminases rose to 
more than 4000 units. The patient became intensely jaundiced and died of hepatic and renal failure. (From Starzl, T. E.: 
Experience in Hfc'patil Transplantation. Philadelphia, W. B. Saunders Company, 1969.) 
pressive program. as will be discussed later. 
HEPATITIS. With the development of 
serologic tests for the detection of hepatitis-
associated antigen (HAA) - also termed the 
Australia (Au) or the hepatitis B (HbAg) 
antig-en - it became possible to test with 
some precision the hypothesis that at least 
some of these cases of liver damage occur-
ring during treatment with dialysis or after 
renal transplantation were due to serum 
hepatitis. 
In 1964 Blumberg and his associates re-
ported the discovery of a foreign substance 
in the serum of Australian aborigines 
(hence the term "Australia antigen"). The 
particle was subsequently identified in the 
blood of patients with leukemia, Down's 
syndrome. leproSY, and serum hepatitis.H 
Prince14 of N ew York reported in 1968 a 
similar antigen in the blood of patients with 
-serum hepatitis (hepatitis B). The two sub-
stances were soon shown to be serologically 
identical and have been termed the hepatitis 
B alltigen (HbAg). 
The nature of the hepatitis B antigen par-
tide and its relationship to the serum hepa-
titis virus have only recently been clarified.50 
Several particles ~arying i;l size and in the 
presence or absence of an R\J A core have 
been isolated and identified by electron mi-
croscopy of liver tissue and centrifugates of 
sera, as summarized in Table 4. 
The current hypothesis holds that the 
Huang particle represents the R\JA-con-
taining (or, possibly, DNA-containing) viral 
core which infects the hepatocyte nucleus.50 
There it replicates and inflicts the liver cell 
damage associated with serum hepatitis. 
The viral cores generated within the nu-
cleus by replication migrate to the cytoplasm 
where they become ensheathed with protein 
coats to form Dane particles. 16 For II n known 
reasons, the cytoplasmic messenger RNA 
directs the production of protein coats (the 
HbAg) a million fold or more in excess of 
that required for the number of viral cores 
present. The excess coats enter the blood 
stream and there can be readily detected as 
Hb antigenemia. but are not infectiye. A few 
Dane particles, containing a viral core 
768 COMPLICATIONS OF TRANSPLANTATION 
TABLE 4 PARTICLES DISCOVERED BY ELECTRONMICROSCOPY IN THE SERUM OR HEPATOCYTES 
OF PATIENTS WITH HEPATITIS B* 
DNA or 
Discoverer Location Size RNA Core Identity 
I. Baver. Prince Serum 
and others 20 11m. dialll. :-.10 Au Ag 
2. Many Serum 20 nm. diam. length 
2-3x that of (I) 
No Another form of Au 
Ag 
3. Dane Serum and cytoplasm 42 11m. cliam. Yes Viral core + .\u Ag 
of hcpatocytes coat 
4. Huang and others Nuclei of he]Jatocytes 23-27 nm. diam. Yes Viral core 
*Data from Maugh. T. H .. II: Hepatitis: A New Understanding- Emerges. Science, 176: 1225, 1 <)72. 
within the protein coat, and therefore infec-
tive, also enter the circulation. 
During an attack of hepatitis B, antibodies 
form against both the core and the protein 
coal. The antibodies against the former per-
sist. frequently for as long as 2 years and are 
thought to be protective, while the anti-
bodies against the protein coat, at least in 
the nonimmunosuppressed patient, usually 
disappear as soon as the HbAg is cleared 
from the svstem.50 
Working with infectious human sera posi-
tive for HbAg, Purcell and others have suc-
ceeded in transmitting subclinical hepatitis 
to rhesus monkeys and chimpanzees, ad-
ding further support to the contention that 
the HbAg is intimately associated with the 
serum hepatitis virus.50 
The appearance of the Australia antigen 
in the blood stream of a transplant recipi-
ent, either preoperatively or in the post-
transplantation period, does not necessarily 
have an unfavorable prognostic significance 
in individual cases Crable 5).10;; Thus, it 
would not seem reasonable to forbid renal 
transplantation to a potential reCIpIent 
merely because of a positive Au serology. 
Nonetheless, screening for Au antigen 
should be a part of the transplant recipient 
(and donor) workup, since documentation 
of Au positivity has certain practical implica-
tions. 
First, the finding should prompt a careful 
evaluation of hepatic function, which, if ab-
normal, should probably include liver 
biopsy. If chronic aggressive hepatitis 
proves to be the diagnosis, the propriety of 
transplantation should be reconsidered. 
Secondly, the patient found to have Aus-
tralia antigen must be regarded as a hepa-
titis carrier and should be managed as such. 
Precautions entail proper techniques of iso-
TABLE 5 LACK OF CORRELATION OF AUSTRALIA ANTIGENEMIA AND HEPATIC DYSFUNCTION 
IN 45 PATIENTS WHO HAD FREQUENT DETERMINATIONS OF LIVER FUNCTION AND IN WHOM 
SEROLOGIC EVIDENCE FOR AUSTRALIA ANTIGEN OR ANTIBODY WAS SOUGHT* 
Deaths 
Number of Patients Attributable to 
Studied None Minort Major:j: Liver Disease 
Au + by all tests 12 5 6 I 0 
All + Il\ complement fixation ani v 7 4 2 1 0 
Au ncgatiye 24 10 \) 5 3 
Ami-Au amihody :2 1 0 1 I 
*Data from Torisu, M .. Yokoyama, '1' .. Amcmi)", B .. Kohler, i'. F., Schrotcr, G .. Martineau, G .. Penn,!.. Palmer, 
W., Halgrirnson. C. G., Putnam, C. W., and Starzl, T. E.: Immunosuppression, Liver Injury, and Hepatitis in 
Renal, Hepatic. and Cardiac lIomograft Recipients: With Particular Refere1lce to the Australia Antigen. AI/II. Smg., 
17Hi20,1971. 
tMinor elevations in the serum Iransaminases ('iO-2;',() I.e.). 
tElevations of the transaminases > 250 I. U. and/or bilirubin> 2 mg./! 00 ml. 
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lation, including stool and needle precau-
tions, and education of paramedical person-
nel. Several transplantation centers have 
already reported deaths from hepatitis 
among their nurses, technicians, and other 
personneJ,105 In this regard, the healthy 
physician, nurse, technician, or relatiye is 
probably at greater risk of developing im-
mediately fatal liver disease than the chroni-
cally ill or immunosuppressed dialysis or 
transplant patient, whereas the prospects of 
having chronic liver disease have seemed to 
us much greater in the population under 
immunosuppression. 
Finally, efforts should be made to protect 
the transplant recipient from unnecessary 
exposure to hepatitis. such as by HbAg-posi-
tive blood products. Au antigen tests should 
also be performed on all prospective organ 
donors. Several cadaveric donors who have 
been pronounced dead in our hospitals on 
the basis of irreversible neurologic injury 
have been discovered to have high titer Au 
antigenemia. If this had not been detected 
in time, several organs would have been 
transplanted from each donor with the vir-
tual certainty of transfer of the hepatitis 
virus to the recipients. 
MODIFICATION OF THE IMMUNOSUPPRES-
SIVE REGIMEN 1:'0.' TIlE PRESEKCE OF HEPATIC 
COMPLICATIONS. In the patient with mod-
erate or severe hepatic dysfunction post 
transplantation or in whom azathioprine 
hepatotoxicity is suspected - usually on the 
[0 ~NAL TRANSPLANT 
basis of progressive hepatic disease in the 
face of a negative result in the search for 
Australia antigen - consideration should be 
given to drastic modifications of the immun-
osuppressive program. Zarday et al.ll3 have 
recommended that in these circumstances 
azathioprine be discontinued entirely and 
that the patient be maintained only with 
steroids. 
Alternatively, substitution of cyclophos-
phamide (Cytoxan) for azathioprine in the 
immunosuppressive regimen has been car-
ried ouLlOl As mentioned previoush'. cyclo-
phosphamide when used in low doses has 
little if any hepatotoxicity. The course of a 
patient in whom such a switch in therapy 
was made is shown in Figure ~O. This girl 
developed fever and extremely severe hepa-
tic dysfunction, including jaundice, while 
under treatment with azathioprine 
(Imuran) and prednisone. It was feared at 
the time that she was dving of liver disease, 
and cyclophosphamide was substituted for 
the suspected guilty agent, azathioprine. 
She completely recovered after the change 
in therapy and remained well for about 1 
year. At that time, azathioprine was restored 
to the regimen and there was recurrence of 
high fever, jaundice, and man v of the same 
symptoms that had been present during the 
previous course of azathioprine. These were 
all promptly relieved by switching once 
more to cyclophosphamide. 
Among our outpatients being followed 
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Figure 20 The course of a 17-year-old female in whom azathioprine was stopped because of the suspicion of hepato-
toxicity. Multiple Australia-antigen tests for serum hepatitis were negative. Note the recession of jaundice after the sub-
stitution of cyclophosphamide for azathioprine. (From Starzl, T. E., et al.: Cyclophosphamide and Whole Organ Trans-
plantation in Humans. Surg., Gynec. & Obst., 133 :981, 1971. By permission of Surgery, Gynecology & Obstetrics.) 
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TABLE 6 INCIDENCE* OF AU ANTIGEN BY 
RANDOM SINGLE SAMPLING IN HOMOGRAFT 
RECIPIENTS FROM ONE MONTH TO 8 YEARS 
AFTER OPERATION, USING IMMUNODIFFUSION 
OR ELECTRO-IMMUNODIFFUSION TESTS 
FOR SCREENINGt 
Number 
of Patients 
Negative 
Au Antigen Anti-Au for Au Antigen 
Positive Antibody and Antibody 
89 15 (16.9'X) 2 (2.2%) 72 (80.990 
*The incidence was actually higher than sholl'll since 
several additional cases were detected within the 
negative group by the more sensitive method of 
complement fixation. 
tFrom Torisll, M .. Yokoyama, T .. Alllemiya. II.. 
Kohler. P. F., Schroter. (~.,- Martineau, C., Pi,nn, L, 
Palmer, W., Halgrimson, C. G .. Putnam, C. W .. and 
Stal'Ll, T. E.: Immunosuppression. Liver Injury, and 
Hepatitis in Renal, Hepatic, and Cardiac Homografl 
Recipients: With Particular Reference to the Australia 
Antigen. AliI!. Smg., 174:620, 1971. 
for up to more than a decade after renal 
transplantation, there are about two dozen 
recipients who have chronic Australia an-
tigenemia (Table 6). Once this serologic 
finding develops in the immunosuppressed 
recipient, it does not go away if it is detecta-
ble by the Ouchterlony method or other 
techniques based on the antigen-antibody 
precipitation principle. We have concluded 
that the treatment with immunosuppression 
has modified the natural course of the 
serum hepatitis, that no specific treatment is 
feasible, and that the best thing to do is to 
try to prevent these patients from transmit-
ting the disease to their family members or 
others. 
HYPERPARATHYROIDISM AND BONE 
DISEASE 
The complication of hyperparathyroi-
dism after transplantation is an example of 
a disorder to the etiology of which preexist-
ing renal failure, as well as the side effects of 
immunosuppressive agents, are presumed 
to make important contrihutions. To begin 
with. secondary hyperparathyroidism is 
present in most patients with chronic renal 
failure. From autopsy studies, it has been 
known for nearly half a century that 
parathyroid hyperplasia is a common find-
ing under these circumstances. The patho-
genesis of the parathyroid lesion has been 
relatively well defined. lo ,76 With advanced 
renal disease and failure of phosphate 
excretion, hyperphosphatemia develops, 
with consequent depression of serum 
calcium. In turn, the hypocalcemia is an 
effective stimulus for parathyroid hyper-
plasia and presumably for heightened 
parathyroid hormone production and re-
lease. 
It is into this environmcnt that many 
renal homo grafts are placed. Since the early 
days of renal homotransplantation, it has 
been thoroughly appreciated that the sec-
ondary hyperparathyroidism persists into 
the immediate postoperative period.5]' 72. 82 
Unfortunately, it has also been accepted by 
most of these investigators that resolution of 
this hyperparathyroidism occurs promptly 
and almost universally,:]' :36,:17 especially if 
high serum calcium values are treated with 
phosphate-containing antacids such as 
Phosphaljcl. With consenati\e manage-
ment, severe hypercalcemia post transplan-
tation has been uncommon, and the dogma 
has become well established that parathyroi-
dectomy is very seldom required. 
. rhe information generated from this 
center in the last 2 years23 has caused us to 
altcr this consenative positiun. Although 
the exact incidence of hyperparathyroidism 
after transplantation cannot yet be accu-
rately stated from our case material, it now 
appears to be at least 20 per cent. The 
insidious feature of the complication has 
been its occult and subtle nature, which in 
some instances, particularly in children. has 
permitted progressive bone changes to 
create a pariah without the features of bio-
chemically florid hyperparathyroidism ever 
having been demonstrated. 
Some of the characteristics of this kind of 
hyperparathyroidism in 18 patients treated 
in the last year and a half at the C niversity 
of Colorado are shown in Table 7.23 Before 
transplantation, all of these recipients had 
suffered from renal failure for at least sev-
eral years and all but one had required 
hemodialysis. There was radiographic evi-
derKe of bone disease in 17 of the 1 R pa-
tients, invariably including osteoporosis. 
However, 10 also had radiographic or 
biopsy evidence of osteitis fibrosis cystica or 
extraskeletal calcification of the arteries or 
soft tissues or both. 
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TABLE 7 CLINICAL DATA ON EIGHTEEN RENAL TRANSPLANT RECIPIENTS AFTER PARATHYROIDECTOMY* 
Radiographic Findings before Parathyroidectomy 
Interval between 
Creatinine Clearance Transplantation Bone Disease 
Age after Transplantation and Parathyroidectomy Extra-Skeletal 
(yrs.) (ml./min.) (mos.) Osteoporosis Osteitis Fibrosa Calcification 
41 95 2 + vascular 
22 70 7 
21 81 14 + vascular 
10 fl5 III + vascular 
~9 49 20 + 
4:1 90 32 + + soft tissue 
27 :,4 47 + -t vascular, skin 
30 \10 54 + 
17 50 63 ++ vascular, soft tissue 
13 :;1 53 + 
30 53 6 + + 
'Ill 119 () + vascular 
32 64 18 +:j: 
I I 46 19 + + soft tisslie 
3~1 74 :I!) + 
24 87 H + 
40 75 2 + -t vascular 
~)~) 71 12 +-:j: 
';'FrOll! Geis, W, P" l'opovtzer, xl, :\1" Corman, l L, llaigrilllsoll, C, C" Groth, C, G" and StanL T E,: The 
Diagnosis ana Treatment of Hyperparathvroidism after Renal Homotransplantation, Surg" C,'lIfc' & Obst" 137: 
997, 1973, By permission of Surgerv, Gynecology E$ Obstetric,l, 
tOsteitis fibrosa cystica histologicallv. 
t,\sel'tic necrosis femoral heael. 
+ Presence of radiographic bone disease, 
- Absence of radiographic bone disease, 
The very serious bone complications in 
such patients may lead to the kind of tragic 
disabilities shown in Figure 21, with bilateral 
aseptic necrosis of the femoral neck. The 
presence of such femoral lesions does not 
ipso facto make the diagnosis of persistent 
hyperparathyroidism, although it should 
arouse suspicion and call for a workup to 
rule out this diagnosis. 
Unfortunately, the determination of lOtal 
serum calcium and phosphorus concentra-
tions in the renal transplant patient may not 
provide adequate screening for the diag-
nosis. In the 18 cases shown ill Table 7, if an 
elevation in total serum calcium were a 
prerequisite for the diagnosis, eight of the 
18 cases of hyperparathyroidism would 
never have been identil1ed. In our clinics, 
heavy reliance has been placed in the recent 
past upon determination of the ionized cal-
cium. This measurement has provided the 
decisive clue in everv case in which it has 
been performed.23 ' 
In much of the older literature, the high 
incidence of osteoporosis and other bone 
abnormalities in the renal transplant recipi-
ent was attributed to chronic therapy with 
prednisone. This concept undoubtedly has 
validity. Steroids have the intrinsic capabil-
ity of causing osteoporosis. In addition, the 
steroids may contribute to the perpetuation 
of preexisting hyperparathyroidism. When 
steroids are administered, they have a de-
pressant effect upon serum calcium COllcen-
tration39• 45 and probably a consequent 
stimulatory effect upon parathyroid hor-
mone induction. 109 Thus, paradoxically. the 
steroids may help control hypercalcemia at 
the price of setting up a vicious cycle aggra-
vating hyperparathyroidism. 
So far, the indications for parathyroidec-
tomy after renal transplantation have un-
doubtedly been too restrictive. It is also clear 
that trying to avoid this operation by 
chronic phosphate administration (as with 
the use of the antacid Phosphaljel) are self-
defeating. If used for long periods of time, 
the phosphate therapy may itself recreate 
the parathyroid stimulus by driving down 
the serum calcium concentration, or it could 
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even, theoretically, aggravate soft tissue 
calci fication ,'15, 109 Consequently, parath yroi-
dectomy should be carefully considered 
after a 3-month period of conservative 
treatment if there is recurrence of the hy-
perparathyroid state after phosphate is 
stopped. The impetus to proceed should be 
increased if there are serious bone compli-
cations in the background or if there is 
unexplained deterioration of re nal homo-
graft function. 
It is of interest that almost two-thirds of 
the patients reviewed in Table 7 had deteri-
orating renal function prior to parathyroi-
dectomy for hyperparathyroidism. After 
operation, this decline was either halted or, 
in almost half the cases, reversed. 
In ordinary clinical practice, hyper-
parathyroidism is usually due to the pres-
ence of an adenoma. in contrast, the diag-
nosis in the renal transplantation patient is 
almost always diffuse hyperplasia. At opera-
tion , before proceeding with resection, it is 
necessary to identify all the parathyroid 
glands. After this has been done , a gland 
with an easily identifiable discrete arterial 
supply is subtotally amputated with a razor 
or scalpel, with a small remnant left intact 
on the vascular stalk. Bleeding from the raw 
surface is controlled with vascular suture or 
cautery. Only after the viability of this rem-
nant is established visually are the other 
glands completely excised . If an accident 
occurs to the remains of the original gland, 
Figure 21 Appearance of asep-
tic necrosis of the femora I head 
(arrow) in a young woman after 
transplantation. She was on 
prednisone therapy at the time of 
this delayed complication. (From 
Starzl , T. E. , et al.: Renal Homo-
transplantation: Late Function and 
Complications. Ann . Int. Med., 
61 :470, 1964.) 
additional opportunities would thereby re-
main available until the last possible mo-
ment. 
An alternative method of treatment is to 
excise all the parathyroid tissue and then 
carry out free autotransplantation of one 
fragment into the sternocleidomastoid or 
some other convenient muscle. This tech-
nique, which has been extensively reviewed 
by Alveryd,4 has the major advantage that it 
permits precise determination, by simple 
metabolic studies carried out within the first 
few postoperative days, of whether all the 
glands have been identified. If all glands 
were found and removed, the tubular phos-
phate reabsorption (TRP) will become 100 
per cent within a few days. Failure to dem-
onstrate this finding signifies that the proce-
dure was incomplete and that at least one 
gland was left behind. After 4 or 5 days, 
TRP begins to be restored and, in our expe-
rience with nine autotransplantations, satis-
factory parathyroid function returns. These 
nine patients are being studied to ma ke sure 
that the cicatricial capsule around the estab-
lished autograft does not, in the long run , 
squeeze off the blood supply many months 
or even years later. Consequentl y, it is our 
plan to carefully follow the nine patients so 
far treated with autotransplantation for sev-
eral years before doing more such proce-
dures. Until then, subtotal parathyroidec-
tomy will continue to be done. 
In this chapter, disproportionate atten-
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tion has been given to the complication of 
hyperparathyroidism for a simple reason. 
The metabolic consequences of this compli-
cation have proved to be truly devastating to 
some of our patients who have been fol-
lowed for almost as long as a decade. By the 
time it was realized that this process was 
going on, irreparable damage had been 
done to their skeletons, particularly in pa-
tients in the pediatric age group, and it is 
suspected that permanent harm was also 
done to the renal homograft itself in some 
cases. 
PROBLEMS OF GROWTH 
In children with chronic uremia, there is 
usually a failure of growth. After successful 
transplantation, the growth retardation as-
sociated with the original disease is replaced 
by whatever inhibition is caused by the ad-
ministration of large doses of steroids. 
Thus, a growth spurt does not ordinarily 
occur early after renal homotransplanta-
tion, and N,~arian and his associates57 
concluded that catch-up growth in pediatric 
patients was not to be expected. However, 
their observations were based on follow-ups 
that were, for the most part, no greater than 
2 years. 
In contrast, our own experience with pe-
diatric patients has been that catch-up 
growth may be seen an extraordinarily long 
time after transplantation, even after a 
delay of as long as 2 to 5 years.46 
Figure 22 Graphic depiction of 
how immunosuppression, while 
permitting acceptance of the homo-
graft, may allow the development 
of infection through a partial loss 
of immunologic surveillance. (From 
Starzl, T. E., et al.: Factors in 
Successful Renal Transplantation. 
Surgery, 56:296, 1964.) 
Bacteria 
PULMONARY DISEASES 
After transplalltation of any of the major 
organs, including the kidney, liver, heart, 
and pancreas, a major source of subsequent 
morbidity has been the lung. Pulmonary 
complications have ranked as either the 
leading or the second most important cause 
of death with different reported series of 
these various kinds of organ transplanta-
tion. A very complete analysis of the role of 
the lung in the deaths of 60 of our early 
renal transplants has been published by Hill 
et a1.30 The complications to which the lung 
is subject in the immunosuppressed organ 
recipient include infection, thromboemboli-
zation, and neoplasia. 
PNEUMONITIS. As emphasized earlier, 
the price for success after organ transplan-
tation under immunosuppression is a par-
tial loss of immunologic surveillance. The 
most dramatic consequence may be infec-
tion. In concept, until about a decade ago, 
many people conceived the problem to 
be insoluble, as depicted in Figure 22. The 
suggestion was that measures to prevcnt the 
rejection of grafts would inevitably permit 
the overgrowth of the contemporaneously 
present bacteria. The pessimism of this view 
has been thoroughly disproved. Neverthe-
less, the margin of safety between therapeu-
tically desirable and lethal immunosuppres-
sion may not be great, and in some cases it 
may not exist at all. As far as the lung is con-
cerned, the margin may be broadened by 
the clever management of pulmonary infec-
tious complications. 
HOST DEFENSE 
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Bocln/({f PIII'WIIOlIllls. A variety of gram-
positive and gram-negative bacteria may 
cause pulmonary infections in immunosup-
pressed organ recipients. The organisms 
presumably gain entry to the lungs by inha-
lation or by descent from an upper respira-
tory tract infection. Because effective antibi-
otics are available for almost all of the 
common pyogenic organisms, accurate 
identifica tion of the organism and determi-
nation of antibiotic sensitivities are essential 
for the successful treatment of bacterial 
pneumonitides. Because bacteremia fre-
quently accompanies these infections, blood 
cultures may be useful for isolation of the 
causative microorganisms, but cultures of 
tracheal aspirates are usually sufficient for 
this purpose. 
Despite the availability of specific antibiot-
ics for these infections, bacterial pneumon-
itis has contributed significantly to the mor-
tality following transplantation. In the early 
days of transplantation, there was a ten-
dency to give too much azathioprine, and if 
bone marrow depression followed, bacterial 
pneumonitides were frequently fata1. 30 In 
more recent years, the doses of either aza-
thioprine or cyclophosphamide have been 
smaller, and granulocytopenia has been cor-
respondingl y rare. However, bacterial 
pneumonitis may still cause occasional 
deaths, particularly if it is complicated by 
3-16-69 
abscess formation, empyema, coexisting de-
vita lization of lung tissue , su ch as by pulmo-
nary emboli , or th e necrotizing vasculitis 
sometimes seen with Pselldolf/OIu/\ anligililisa 
pneu monitis. 
FUligaf P'Ill'1.lInolli/is. The avoidance of 
bone marrow depression has by no means 
eliminated infections by microorganisms of 
normally low pathogenicity for which truly 
effective and safe antibiotic therapy is not 
available. Fungal pneumonitides have been 
a common cause of late morbidity and 
mortality,30. 85, 87. 88 the most frequently 
noted microorganisms in our series being 
Calldida albimns and AS/Jl'IgillvsjLlIlliga/us, al-
though in geographic areas in which Coc-
cidioides and Histoplasma are endemic, in-
fections with these fungi might be 
anticipated with greater frequency. Funga l 
infestation of the lungs may present as a dif-
fuse pneumonitis or more commonly as a 
nodular lesion, which subsequentl y cavitates 
(Fig. 23). The diagnosis should be enter-
tained in any recipient with a pulmonary in-
fection in whom a bacterial etiology cannot 
be convincingly established or in whom the 
lesions are exacerbated by appropriate an-
tibacterial therapy. A definitive diagnosis 
may sometimes be made from examination 
and cultures of tracheobronchial aspirates 
or of material obta ined by the endobron-
chial brush technique of Fennessey20 Nei-
Figure 23 Chest x-ray of a pa-
tient with fatal Aspergillus fumiga-
tus pneumonia. Note the cavitary 
lesions in the right lung field and 
the nodular les ions in the opposite 
lung (arrows). (From Pappas, G., 
et al.: Pulmonary Surgery in Im-
munosuppressed Patients. /. 
Thora c. & Cardiovasc. Surg . 59: 
882, 1970) 
